• 한국수정란이식학회지
• /
• 제15권1호
• /
• pp.85-94
• /
• 2000

These experiments were conducted to examine the effects of theophylline, pentoxifylline and heparin on frozen-thawed Hanwoo sperm for enhancing motility and viability of sperm. Frozen-thawed semen collected from one bull was treated in TALP(tyrode-albuminlactate-pyruvate) containing varous concentrations of theophylline and pentoxifylline. After incubated at 5% CO2 in air atmosphere for 6 hours, the motility of sperm after the treatments was characterized by CASA(computer aided semen analysis) system. When monitored notility(MOT) and curvilinear velocity(VCL), theophylline and pentoxifylline exerted their optimal action at the concentration of 30 mM and 3 mM, respectively. No difference of sperm motility was observed when the sperm was treated with both substances compared with a single treatment of each substance. Comparison was then made for evaluating the effect of theophylline and / or pentoxiophylline on the motility and viability of significant treatment effects of each substance, high MOT and VCL values were detected in sperm treated with theophylline. In the case of sperm viability examined by an eosin-nigrosin staining, however, a significant decrease was found after the combined treatment of theophylline+pentoxyphilline than after the treatment with heparin alone or no treatment(P<0.05). In conclusion, theophylline, pentoxiphylline or heparin can be used for enhancing the motional characteristics and viability of frozen thawed Hanwoo semen. Considering characteristics of these substances, theophyline may be useful in the artificial insemination system, which requires vigorous sperm motility. While, heparin supporting sperm viability in vitro can be effectively used for improving in vitro-fertilization system.

• Archives of Pharmacal Research
• /
• 제22권1호
• /
• pp.60-67
• /
• 1999

The object of this work was to study the pharmacokinetic differences and the cause of these differences in cirrhotic rats induced by biliary obstruction when aminophylline (8 mg/kg as theophylline, i.v.) was administered. The concentrations of theophylline and its major metabolite (1,3-dimethyluric acid) in plasma were determined by HPLC. In addition, formation of 1,3-dimethyluric acid from theophylline in microsomes and the changes in the activity of drug metabolizing enzymes, which are suggested to be involved in theophylline metabolism, were determined. In cirrhotic rats, the systemic clearance of theophylline was reduced to 30% of the control value while AUC (area under the palsma concentration-tie curve) and (t1/2)$\beta$ were increased 1.3 fold and3.5 fold, respectively. The formation of 1,3-dimethyluric acid was decreased to 30% of the control value in microsomes of cirrhotic rat liver. In cirrhotic rat liver, activities of aniline hydroxylase (CYP2E1 related), erythromycin-N-demethylase (CYP3A related), and methoxyresorufin-O-demethylase (CYP1A2 related), which were reported to be related with theophyline metabolism, were decreased to 67%, 53%, and 76% that of normal rat liver, respectively. From the results, it can be concluded that in cirrhotic rats induced by biliary obstruction, the total body clearance of theophylline is markedly reduced and it may be due to decreased activity of drug metabolizing enzymes in liver.

• 약학회지
• /
• 제35권1호
• /
• pp.38-44
• /
• 1991

It has been reported that the pharmacokinetic behaviors of drugs which are mostly metabolized in the liver are significantly different in patients with renal failure. Theophylline(TP) is mainly metabolized in the liver (approximately 90%) and renal clearance of the drug is negligible (less than 10%). Therefore, we have investigated the changes in pharmacokinetics of theophylline in normal, G-ARF and U-ARF rats after an intravenous administration. The total body clearance of TP decreased approximately 40% in U-ARF rats. The reduced CL$_{T}$, value in U-ARF rats could be due to reduced hepatic intrinsic clearance by up to 40% since it has been published that plasma protein binding of TP and liver blood flow does not change in U-ARF rats.

• 약학회지
• /
• 제36권4호
• /
• pp.321-325
• /
• 1992

Pharmacokinetic interaction of theophylline with pefloxacin following i.v. administrations was investigated in rabbits. Pefloxacin was coadministrated at doses of 10 and 20 mg/kg or previously administered for 6 days 10 and 20 mg/kg. Plasma concentration and AUC of theophylline were increased significantly (p<0.05) and the renal clearance $(CL_r)$, total body clearance $(CL_r)$ and the volume of distribution $(Vd_{ss})$ were decreased significantly (p<0.005) by the pretreatment. It demonstrates that adjustment of dosage regimen of theophylline should be considered when concomitant administration of pefloxacin is prescribed.

• Tuberculosis and Respiratory Diseases
• /
• 제48권6호
• /
• pp.898-908
• /
• 2000

연구배경 : 기도의 알레르기성 질환에서는 기도점막에 발생하는 염증 특히 호산구의 집결 및 침윤의 역할이 중요하다. Eotaxin은 CC chemokine으로서 호산구에만 선택적으로 작용하여 조직으로의 호산구의 집결을 유도한다. Theophylline의 항염증작용은 기관지천식 치료에 중요한 기전의 하나로 생각되며 특히 호산구성 기도염증에 관여하는 여러 인자들을 조절하는 작용이 중요하다. 본 연구는 theophylline의 향염증작용이 eotaxin mRNA의 발현 억제를 통해 이루어지는지 알아보고자 하였다. 방법 : A549 세포를 배양하여 IL-$\beta$ 또는 TNF-$\alpha$로 자극한 후 Northern blot analysis를 시행하여 eotaxin mRNA의 발현율 관찰하였다. 그 후에 theophylline을 가하여 발현을 관찰하였다. 결과 : A549 세포에서 cytokine으로 유도된 eotaxin mRNA의 발현은 TNF-$\alpha$ 자극 후 $\beta$-actin과 비교한 발현율은 0.1, 1, 10 ng/mL의 농도에서 각각 7%, 22%, 28% 였고 IL-$\beta$ 자극 후 0.01, 0.1, 1, 10 ng/mL의 농도에서 각각 10%, 42%, 63%. 72%로서 cytokine의 농도가 증가할수록 eotaxin mRNA의 발현이 증가하였다. Dexamethasone투여 후 eotaxin mRNA의 발현율은 TNF-$\alpha$로 자극한 경우 0, 0.001, 0.01 ${\mu}M$의 dexamethasone농도에서 각각 27%, 18%, 8% 였고 IL-$\beta$로 자극한 경우 0, 0.001, 0.01, 0.1 ${\mu}M$의 농도에서 각각 43%, 47%, 12%, 8%로서 dexamethasone의 농도가 증가함에 따라 발현이 감소되었다. Theophylline 투여 후 IL-$\beta$로 자극한 경우 eotaxin mRNA의 발현율은 0, 0. 001, 0.01, 0.1, 1, 10 mM의 theophylline농도에서 각각 48%, 40%, 33%, 22%, 16%, 14% 로서 theophylline의 농도가 증가함에 따라 발현이 감소되었다. 결론 : Theophylline의 항호산구성 염증작용은 eotaxin mRNA의 발현을 억제함으로써 이루어짐을 알 수 있었다.

• 대한화학회지
• /
• 제22권2호
• /
• pp.86-94
• /
• 1978

Theophylline 鹽酸鹽의 結晶 및 分子 構造를 3次元的인 X-線 回折 data로부터 Patterson法에 의하여 決定하였고, Block-diagonal least square와 Fourier法으로서座標를 精密化하였다. 이化合物은 a = 14.01, b = 11.49, c = 6.77${\AA}$의 單位格子를 가지는 斜方晶系에 屬하는 結晶 이며 空間群은 $P_{na21}$ 이다. 743개의 觀測된 data에 대한 최종 R값은 12.2%이다. Theophylline 分子內 原子間 距離는 유사化合物에서 얻은 값과 거의 일치한다. 이들 原子는 同一平面을 이루고 있으며 HCl의 鹽素原子는 theophylline의 N(1) 原子와 3.06${\AA}$ 距離의 Cl${\cdot}{\cdot}{\cdot}$N(1), 水素結合을 이루고 있다. 모든 分子 는 대략 (001)과 (002)面上에 배열되어 있고 各分子間은 van derWaals force에 의해 三次元的 構造를 이루고 있다.

• Archives of Pharmacal Research
• /
• 제19권5호
• /
• pp.396-399
• /
• 1996

High-performance liquid chromatographic method with UV detecction was developed for the determination of theophylline and its metabolites in human urine using ${beta}$-hydroxyethyl theophylline$({beta} -HET)$ as an internal standard. For extraction of urine sample, quality control sample and xanthine-free blank urine were mixed with decylamine (ion-paring reagent) and ${beta}$-HET. After saturation with ammonium sulfate, the mixture was then extracted with organic solvent at pH values of 4.0-4.5. All separations were performed with ion-pair chromatography using decylamine as an ion-pairing reagent and 3mM sodium acetate buffered mobile phase (pH 4.0) containing 1% (v/v) acetonitrile and 0.75 mM decylamine. The detection limits of theophylline, 1, 3-DMU, 1-MU, 3-MX and 1-MX in human urine were 0.17, 0.17, 0.39, 0.19 and 0.19 ${\mu}g$/ml, based on a signal-to-noise ratios of 3.0. The mean intraday coefficients of variation (C.V.s) of each compound on nine replicates were lower than 2.0%, while mean interday C.V.s on three days were lower than 1.6%. All separations were finished within 40miutes.

• 한국의료질향상학회지
• /
• 제7권2호
• /
• pp.168-179
• /
• 2000

Background : Economic evaluation of clinical pharmacokinetic consultation services for theophylline, which is being widely used recently, is considered in patients for both proper care and cost efficiency. Mathods : This is a cost-benefit analysis of clinical pharmacokinetic consultation service for theophylline. Trial groups were chosen from 2 general hospitals which was performing clinical pharmacokinetic consultation- services in 1998. Control group was chosen from another one general hospital. The analysis includes 25 patients (sample patients) for trial group and 17 patients for control group. Results : On the basis of incremental analysis, it is estimated that the total (direct and indirect) annual costs of the clinical, pharmacokinetic services of theophylline for the patients in the trial group was about \65 million, whereas total annual benefits from those services was estimated to be about \551 million. The net benefits incurred to the sample patients, thus calculated, was about \485 million per year. In the analysis, we assumed that indirect benefits accruing to those services were non-existent. If that amount was included, the estimated net benefits would be much greater than the calculated one. Conclusion : We found that clinical pharmacokinetic consultation services for theophylline could produce more marginal benefits than marginal costs by those services from the social point of view. More controlled prospective trial in the future would be helpful for affirmation of the results of this study.

• Tuberculosis and Respiratory Diseases
• /
• 제50권3호
• /
• pp.293-299
• /
• 2001

연구배경 : Theophylline은 천식 치료에 있어 효과적이고 쉽게 사용할 수 있는 약물 중의 하나이다. 그러나 치료영역이 좁아 혈청농도의 적은 변화에도 독성증상이 나타나거나 약물효과를 나타내지 않는 경우가 발생할 수 있다. 또한 일상적인 1일 2회 제형은 1일 1회 제형에 비해 순응도를 낮은 단점이 있다. 저자들은 1일 2회 제형인 에테오필$^{(R)}$ 1일 1회 제형인 유니필$^{(R)}$을 천식환자에게 투여 후 혈청 농도측정과 폐기능 검사를 시행하여 두 제형외 약효비교와 한국인에서도 1일 1회 제형의 사용이 보편화될 수 있는지에 대해 알아보고자 하였다. 방 법 : 28일동안 에테오필$^{(R)}$ 200mg 이나 400mg을 하루 2회 오전 8시와 오후 8시에 분복하도록 하였으며 28일째 오후 7시에 theophylline 혈청 농도와 폐기능 검사를 시행하고 29일째부터 동량의 유니필$^{(R)}$을 오후 8시에 1회 복용하도록 하였다. 56일째 오후 7시에 theophylline 혈청 농도와 폐기능 검사를 다시 시행하여 비교하였다. 결 과 : Theophylline 혈청 농도는 에테오필$^{(R)}$ 투여기간에 $8.18{\pm}1.66{\mu}g/ml$, 유니필$^{(R)}$투여기간에서 $8.00{\pm}1.75{\mu}g/ml$로 통계학적으로 유의한 차이는 보이지 않았다. 폐기능 검사에서 노력형 1초 호기량 역시, 에테오필$^{(R)}$ 투여기간에 $71.40{\pm}7.48%$, $69.18{\pm}9.00%$로 통계학적으로 유의한 차이는 보이지 않았다. 결 론 : 유니필$^{(R)}$ 투여기간과 기존의 에테오필$^{(R)}$ 투여기간을 비교할 때, 통계적으로 유의한 차이가 없는 정도의 theophylline 혈청 농도와 노력성 1초 호기량올 보여줌으로서 천식치료에서 1일 1회 제형의 유니필$^{(R)}$ 사용의 객관적 근거로 제시될 수 있었다.

• 한국임상약학회지
• /
• 제27권2호
• /
• pp.113-118
• /
• 2017

Objective: International institutes such as Global institute for Asthma(GINA), KAAACI(Republic of Korea), NHLBI(USA), BTS(UK) and JSA(Japan) have published guidelines for asthma treatment. The aim of this study was to compare the representatives' international guidelines of pharmacotherapy for pediatric asthma. Methods: The recommendations related to pharmacotherapy for pediatric asthma were extracted from the latest representatives' international guidelines, and comprehensive comparisons were conducted. Results: Major comparison outcomes between international guidelines were evaluated as follows: classification system on severity and pediatric age group, recommendation for inhaled corticosteroid dose, recommendation for pediatric age group of theophylline in mild asthma, and recommendation for pediatric age group of tiotropium in severe asthma. Clinical trials emphasized the adverse effects of theophylline, whereas tiotropium demonstrated beneficial actions for pediatric asthma. Therefore, theophylline was recommended for older patients with persistent asthma, and tiotropium was considered to be suitable for younger patients with severe asthma according to GINA guidelines. Conclusion: These findings address the requirement to harmonize international guidelines of pharmacotherapy in pediatric asthma. In addition, the findings suggest that KAAACI needs to update its pharmacotherapy guidelines of theophylline, tiotropium and other medicines recently approved.